Partners in crime: Autoantibodies complicit in COVID‐19 pathogenesis
Autoantibodies (AABs) play a critical role in the pathogenesis of autoimmune diseases (AIDs) and serve as a diagnostic and prognostic tool in assessing these complex disorders. Viral infections have long been recognized as a principal environmental factor affecting the production of AABs and the dev...
Saved in:
Published in | Reviews in medical virology Vol. 33; no. 2; pp. e2412 - n/a |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Periodicals Inc
01.03.2023
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Autoantibodies (AABs) play a critical role in the pathogenesis of autoimmune diseases (AIDs) and serve as a diagnostic and prognostic tool in assessing these complex disorders. Viral infections have long been recognized as a principal environmental factor affecting the production of AABs and the development of autoimmunity. COVID‐19 has primarily been considered a hyperinflammatory syndrome triggered by a cytokine storm. In the following, the role of maladaptive B cell response and AABs became more apparent in COVID‐19 pathogenesis. The current review will primarily focus on the role of extrafollicular B cell response, Toll‐like receptor‐7 (TLR‐7) activation, and neutrophil extracellular traps (NETs) formation in the development of AABs following SARS‐CoV‐2 infection. In the following, this review will clarify how these AABs dysregulate immune response to SARS‐CoV‐2 by disrupting cytokine function and triggering neutrophil hyper‐reactivity. Finally, the pathologic effects of these AABs will be further described in COVID‐19 associate clinical manifestations, including venous and arterial thrombosis, a multisystem inflammatory syndrome in children (MIS‐C), acute respiratory distress syndrome (ARDS), and recently described post‐acute sequelae of COVID‐19 (PASC) or long‐COVID. |
---|---|
AbstractList | Autoantibodies (AABs) play a critical role in the pathogenesis of autoimmune diseases (AIDs) and serve as a diagnostic and prognostic tool in assessing these complex disorders. Viral infections have long been recognized as a principal environmental factor affecting the production of AABs and the development of autoimmunity. COVID-19 has primarily been considered a hyperinflammatory syndrome triggered by a cytokine storm. In the following, the role of maladaptive B cell response and AABs became more apparent in COVID-19 pathogenesis. The current review will primarily focus on the role of extrafollicular B cell response, Toll-like receptor-7 (TLR-7) activation, and neutrophil extracellular traps (NETs) formation in the development of AABs following SARS-CoV-2 infection. In the following, this review will clarify how these AABs dysregulate immune response to SARS-CoV-2 by disrupting cytokine function and triggering neutrophil hyper-reactivity. Finally, the pathologic effects of these AABs will be further described in COVID-19 associate clinical manifestations, including venous and arterial thrombosis, a multisystem inflammatory syndrome in children (MIS-C), acute respiratory distress syndrome (ARDS), and recently described post-acute sequelae of COVID-19 (PASC) or long-COVID. Abstract Autoantibodies (AABs) play a critical role in the pathogenesis of autoimmune diseases (AIDs) and serve as a diagnostic and prognostic tool in assessing these complex disorders. Viral infections have long been recognized as a principal environmental factor affecting the production of AABs and the development of autoimmunity. COVID‐19 has primarily been considered a hyperinflammatory syndrome triggered by a cytokine storm. In the following, the role of maladaptive B cell response and AABs became more apparent in COVID‐19 pathogenesis. The current review will primarily focus on the role of extrafollicular B cell response, Toll‐like receptor‐7 (TLR‐7) activation, and neutrophil extracellular traps (NETs) formation in the development of AABs following SARS‐CoV‐2 infection. In the following, this review will clarify how these AABs dysregulate immune response to SARS‐CoV‐2 by disrupting cytokine function and triggering neutrophil hyper‐reactivity. Finally, the pathologic effects of these AABs will be further described in COVID‐19 associate clinical manifestations, including venous and arterial thrombosis, a multisystem inflammatory syndrome in children (MIS‐C), acute respiratory distress syndrome (ARDS), and recently described post‐acute sequelae of COVID‐19 (PASC) or long‐COVID. |
Author | Shamsi, Afsaneh Soufivand, Parviz Feizollahi, Parisa Assar, Shirin Vaziri, Siavash Asghariazar, Vahid Safarzadeh, Elham Jalili, Cyrus Nicknam, Mohammad Hossein Asgarzadeh, Ali Roghani, Seyed Askar Taghadosi, Mahdi Pournazari, Mehran Shahriari, Hossein Mohammadi, Asadollah |
AuthorAffiliation | 7 Department of Immunology School of Medicine Tehran University of Medical Sciences Tehran Iran 12 Cellular and Molecular Research Center Research Institute for Health Development Kurdistan University of Medical Sciences Sanandaj Iran 2 Department of Microbiology, Parasitology, and Immunology Ardabil University of Medical Sciences Ardabil Iran 3 Students Research Committee School of Medicine Ardabil University of Medical Sciences Ardabil Iran 8 Molecular Immunology Research Centre Tehran University of Medical Sciences Tehran Iran 4 Medical Biology Research Center Health Technology Institute Kermanshah University of Medical Sciences Kermanshah Iran 9 Deputy of Research and Technology Ardabil University of Medical Sciences Ardabil Iran 11 Clinical Immunology Research Center Zahedan University of Medical Sciences Zahedan Iran 10 Infectious Disease Research Center Kermanshah University of Medical Sciences Kermanshah Iran 5 Clinical Research Development Center Imam Reza Hospital Kermanshah Universit |
AuthorAffiliation_xml | – name: 5 Clinical Research Development Center Imam Reza Hospital Kermanshah University of Medical Sciences Kermanshah Iran – name: 9 Deputy of Research and Technology Ardabil University of Medical Sciences Ardabil Iran – name: 1 Immunology Department Faculty of Medicine Kermanshah University of Medical Sciences Kermanshah Iran – name: 4 Medical Biology Research Center Health Technology Institute Kermanshah University of Medical Sciences Kermanshah Iran – name: 6 Department of Anatomy Kermanshah University of Medical Sciences Kermanshah Iran – name: 12 Cellular and Molecular Research Center Research Institute for Health Development Kurdistan University of Medical Sciences Sanandaj Iran – name: 3 Students Research Committee School of Medicine Ardabil University of Medical Sciences Ardabil Iran – name: 7 Department of Immunology School of Medicine Tehran University of Medical Sciences Tehran Iran – name: 11 Clinical Immunology Research Center Zahedan University of Medical Sciences Zahedan Iran – name: 8 Molecular Immunology Research Centre Tehran University of Medical Sciences Tehran Iran – name: 10 Infectious Disease Research Center Kermanshah University of Medical Sciences Kermanshah Iran – name: 2 Department of Microbiology, Parasitology, and Immunology Ardabil University of Medical Sciences Ardabil Iran |
Author_xml | – sequence: 1 givenname: Mahdi orcidid: 0000-0002-3516-0130 surname: Taghadosi fullname: Taghadosi, Mahdi email: mtaghad@gmail.com organization: Kermanshah University of Medical Sciences – sequence: 2 givenname: Elham surname: Safarzadeh fullname: Safarzadeh, Elham organization: Ardabil University of Medical Sciences – sequence: 3 givenname: Ali surname: Asgarzadeh fullname: Asgarzadeh, Ali organization: Ardabil University of Medical Sciences – sequence: 4 givenname: Seyed Askar surname: Roghani fullname: Roghani, Seyed Askar organization: Kermanshah University of Medical Sciences – sequence: 5 givenname: Afsaneh surname: Shamsi fullname: Shamsi, Afsaneh organization: Kermanshah University of Medical Sciences – sequence: 6 givenname: Cyrus surname: Jalili fullname: Jalili, Cyrus organization: Kermanshah University of Medical Sciences – sequence: 7 givenname: Shirin surname: Assar fullname: Assar, Shirin organization: Kermanshah University of Medical Sciences – sequence: 8 givenname: Parviz surname: Soufivand fullname: Soufivand, Parviz organization: Kermanshah University of Medical Sciences – sequence: 9 givenname: Mehran surname: Pournazari fullname: Pournazari, Mehran organization: Kermanshah University of Medical Sciences – sequence: 10 givenname: Parisa surname: Feizollahi fullname: Feizollahi, Parisa organization: Kermanshah University of Medical Sciences – sequence: 11 givenname: Mohammad Hossein surname: Nicknam fullname: Nicknam, Mohammad Hossein organization: Tehran University of Medical Sciences – sequence: 12 givenname: Vahid surname: Asghariazar fullname: Asghariazar, Vahid organization: Ardabil University of Medical Sciences – sequence: 13 givenname: Siavash surname: Vaziri fullname: Vaziri, Siavash organization: Kermanshah University of Medical Sciences – sequence: 14 givenname: Hossein surname: Shahriari fullname: Shahriari, Hossein organization: Zahedan University of Medical Sciences – sequence: 15 givenname: Asadollah surname: Mohammadi fullname: Mohammadi, Asadollah organization: Kurdistan University of Medical Sciences |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36471421$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kMFKAzEURYNUtK2CXyADbtxMTTKZycSFUKpVQamIug1p5o2mtElNpoo7P8Fv9EtMrYouJIsXeIfzLreDWtZZQGiH4B7BmB742VOPMkLXUJtgIVJS5Ky1_Oc0FZQXm6gTwgRjEh_bQJtZwThhlLTR8Er5xoIPibGJ9mYGh0l_0ThlGzN2lYGQaDebT402zRIZjO7Oj99f34hI5qp5cPdgIZiwhdZrNQ2w_TW76HZ4cjM4Sy9Gp-eD_kWqWVbSVNFaKMYLpeqiEjzPixwLXGNcZQIUYYBZhQEwqRgHIjTWZZZXahxzCy2gzrroaOWdL8YzqDTYxqupnMfgyr9Ip4z8u7HmQd67JylKzjnLo2DvS-Dd4wJCIydu4W3MLCkvc1JygrNI7a8o7V0IHuqfCwTLZeMyNi6XjUd093eiH_C74gikK-DZTOHlX5G8vrz7FH4AunyM6A |
CitedBy_id | crossref_primary_10_3389_fimmu_2023_1254310 crossref_primary_10_4330_wjc_v16_i5_260 crossref_primary_10_1002_iid3_1276 crossref_primary_10_3390_antib12030049 crossref_primary_10_3389_fgene_2024_1383162 |
Cites_doi | 10.1016/s0140‐6736(04)16154‐0 10.1016/j.jinf.2020.04.041 10.3390/v13020260 10.1172/jci154886 10.1038/s41598‐020‐76781‐0 10.1186/1479‐5876‐8‐97 10.1038/s41584‐020‐00544‐4 10.1126/sciimmunol.abl4348 10.1038/s41584‐020‐00522‐w 10.1016/j.medj.2022.04.001 10.1126/science.abc6261 10.3390/v13020277 10.1080/1040841x.2019.1614904 10.1089/vim.2016.0179 10.1038/ncomms8375 10.1126/science.abd4585 10.1007/s10456‐008‐9101‐9 10.1007/s40744‐021‐00334‐8 10.3389/fphar.2020.601685 10.1038/s41586‐021‐03631‐y 10.3389/fimmu.2021.659339 10.1016/j.jaut.2018.10.012 10.1126/science.1093616 10.1038/s41590‐021‐01104‐y 10.1097/bor.0000000000000398 10.1172/jci.insight.150111 10.1016/j.clim.2021.108694 10.1038/nrrheum.2017.124 10.1371/journal.pone.0179981 10.1038/s41591‐022‐01766‐7 10.3390/ijms21041382 10.1016/j.cell.2020.09.016 10.1038/s41591‐021‐01283‐z 10.3390/v11080762 10.1016/j.xcrm.2021.100321 10.1038/s41467‐021‐25509‐3 10.1016/j.autrev.2021.103012 10.1038/srep29532 10.1073/pnas.071050898 10.1016/j.cell.2022.01.014 10.1016/j.cell.2020.09.034 10.3389/fimmu.2019.01517 10.3389/fendo.2017.00159 10.3389/fimmu.2022.732197 10.1016/j.vph.2021.106946 10.1038/s41591‐022‐01689‐3 10.1186/1471‐2172‐15‐10 10.1016/s0140‐6736(20)30183‐5 10.1007/s10875‐019‐00737‐x 10.1016/j.ijpara.2020.08.003 10.1186/s12967‐021‐03184‐8 10.1038/s41590‐020‐00814‐z 10.1038/s41575‐019‐0226‐7 10.1126/sciimmunol.abl4340 10.1136/jclinpath‐2015‐203455 10.1016/j.cell.2020.11.032 10.1016/j.semarthrit.2005.09.002 10.1016/j.jaut.2019.06.012 10.3389/fmicb.2021.698169 10.3389/fimmu.2019.00318 10.1016/j.cell.2020.08.025 10.1016/j.immuni.2018.08.015 10.1056/nejm199912303412707 10.1016/j.intimp.2021.107806 10.1126/scitranslmed.3005580 10.5114/ceji.2016.63130 10.1126/scitranslmed.abd3876 10.1016/j.autrev.2020.102597 10.1007/s11154‐016‐9363‐2 10.1007/s12016‐007‐8013‐6 10.1177/0961203314558677 10.1038/ni.3731 10.5858/2007‐131‐452‐aaicvb 10.1016/j.jaut.2012.11.001 10.1136/ard.62.5.388 10.1038/s41423‐020‐0492‐x 10.1016/s2665‐9913(22)00064‐9 10.1002/jmv.26826 10.1016/j.jneuroim.2021.577636 10.1084/jem.20071859 10.1016/j.autrev.2016.03.020 10.1136/annrheumdis‐2020‐218009 10.1126/science.1092385 10.1038/ni1457 10.1186/ar3822 10.3389/fimmu.2017.01075 10.3389/fphar.2021.708302 10.1038/s41423‐020‐00542‐2 10.1038/s41586‐022‐04642‐z 10.1038/nrneph.2016.71 10.1007/s12026‐014‐8596‐y 10.1126/science.aac4919 10.1038/cmi.2017.142 10.4103/1673‐5374.245462 10.1016/j.immuni.2006.07.013 10.1056/nejmoa2021756 10.1111/cts.12805 |
ContentType | Journal Article |
Copyright | 2022 John Wiley & Sons Ltd. 2023 John Wiley & Sons Ltd. |
Copyright_xml | – notice: 2022 John Wiley & Sons Ltd. – notice: 2023 John Wiley & Sons Ltd. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7U9 8FD FR3 H94 K9. P64 RC3 5PM |
DOI | 10.1002/rmv.2412 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Virology and AIDS Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts Genetics Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Genetics Abstracts Virology and AIDS Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Engineering Research Database Biotechnology and BioEngineering Abstracts |
DatabaseTitleList | MEDLINE Genetics Abstracts CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1099-1654 |
EndPage | n/a |
ExternalDocumentID | 10_1002_rmv_2412 36471421 RMV2412 |
Genre | reviewArticle Journal Article Review |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 29P 31~ 33P 3SF 3V. 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 88A 88E 8CJ 8FE 8FH 8FI 8FJ 8R4 8R5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABPVW ABQWH ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFKRA AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BBNVY BDRZF BENPR BFHJK BHBCM BHPHI BMXJE BPHCQ BROTX BRXPI BVXVI BY8 C45 CCPQU CS3 D-6 D-7 D-E D-F D1J DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD ELTNK EMOBN F00 F01 F04 F5P FEDTE FUBAC FYUFA G-S G.N GNP GODZA H.X HBH HCIFZ HF~ HGLYW HHY HHZ HMCUK HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LK8 LOXES LP6 LP7 LUTES LW6 LYRES M0L M1P M65 M7P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ PROAC PSQYO Q.N Q11 Q2X QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 SAMSI SUPJJ SV3 TEORI UB1 UKHRP V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7U9 8FD FR3 H94 K9. P64 RC3 5PM |
ID | FETCH-LOGICAL-c4382-a2f9a476aaf6d975565090f00d39ea14e04d0ee01d47e19c0c835dab1019c9ef3 |
IEDL.DBID | DR2 |
ISSN | 1052-9276 |
IngestDate | Tue Sep 17 21:30:23 EDT 2024 Thu Oct 10 22:01:56 EDT 2024 Fri Aug 23 01:09:48 EDT 2024 Sat Sep 28 08:16:42 EDT 2024 Sat Aug 24 01:07:11 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | COVID-19 SARS-CoV-2 autoimmunity autoantibody (AAB) |
Language | English |
License | 2022 John Wiley & Sons Ltd. This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4382-a2f9a476aaf6d975565090f00d39ea14e04d0ee01d47e19c0c835dab1019c9ef3 |
ORCID | 0000-0002-3516-0130 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC9877745 |
PMID | 36471421 |
PQID | 2785187103 |
PQPubID | 30417 |
PageCount | 17 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9877745 proquest_journals_2785187103 crossref_primary_10_1002_rmv_2412 pubmed_primary_36471421 wiley_primary_10_1002_rmv_2412_RMV2412 |
PublicationCentury | 2000 |
PublicationDate | March 2023 |
PublicationDateYYYYMMDD | 2023-03-01 |
PublicationDate_xml | – month: 03 year: 2023 text: March 2023 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Chichester – name: Hoboken |
PublicationTitle | Reviews in medical virology |
PublicationTitleAlternate | Rev Med Virol |
PublicationYear | 2023 |
Publisher | Wiley Periodicals Inc John Wiley and Sons Inc |
Publisher_xml | – name: Wiley Periodicals Inc – name: John Wiley and Sons Inc |
References | 2021; 27 2004; 363 2017; 8 2006; 35 2019; 11 2019; 10 2019; 14 2020; 369 2020; 17 2022; 23 2020; 16 2008; 34 2020; 13 2020; 12 2022; 21 2015; 349 2020; 11 2020; 10 2012; 14 2013; 5 2018; 49 2022; 28 2020; 19 2017; 30 2020; 50 2021; 358 2020; 370 2006; 25 2007; 131 2007; 8 2014; 15 2016; 41 2021; 595 2022; 605 2010; 8 2001; 98 2021; 8 2021; 6 2004; 303 2015; 6 2021; 2 2020; 383 2020; 40 2021; 226 2020; 181 2020; 81 2013; 42 2020; 183 1999; 341 2019; 103 2008; 205 2020; 79 2008; 11 2017; 29 2021; 93 2016; 17 2016; 15 2016; 12 2015; 24 2021; 13 2022; 142 2016; 6 2021; 98 2022; 185 2021; 12 2012; 1 2022; 3 2022; 4 2020; 395 2015; 61 2019; 45 2021; 17 2017; 13 2021; 19 2017; 12 2022; 13 2021; 131 2017; 18 2018; 95 2020; 21 2003; 62 2016; 69 2018; 15 e_1_2_15_42_1 e_1_2_15_88_1 e_1_2_15_69_1 e_1_2_15_3_1 e_1_2_15_80_1 e_1_2_15_27_1 e_1_2_15_61_1 e_1_2_15_46_1 e_1_2_15_84_1 e_1_2_15_23_1 e_1_2_15_65_1 e_1_2_15_7_1 e_1_2_15_31_1 e_1_2_15_77_1 e_1_2_15_58_1 e_1_2_15_100_1 e_1_2_15_39_1 e_1_2_15_16_1 e_1_2_15_50_1 e_1_2_15_92_1 e_1_2_15_35_1 e_1_2_15_73_1 e_1_2_15_12_1 e_1_2_15_54_1 e_1_2_15_96_1 e_1_2_15_20_1 e_1_2_15_43_1 e_1_2_15_89_1 Cappellano G (e_1_2_15_66_1) 2012; 1 e_1_2_15_28_1 e_1_2_15_81_1 e_1_2_15_2_1 e_1_2_15_24_1 e_1_2_15_47_1 e_1_2_15_62_1 e_1_2_15_85_1 e_1_2_15_6_1 e_1_2_15_32_1 e_1_2_15_55_1 e_1_2_15_78_1 e_1_2_15_59_1 e_1_2_15_17_1 e_1_2_15_70_1 e_1_2_15_93_1 e_1_2_15_13_1 e_1_2_15_36_1 e_1_2_15_51_1 e_1_2_15_74_1 e_1_2_15_97_1 e_1_2_15_21_1 e_1_2_15_67_1 e_1_2_15_40_1 e_1_2_15_29_1 e_1_2_15_48_1 e_1_2_15_82_1 e_1_2_15_25_1 e_1_2_15_63_1 e_1_2_15_44_1 e_1_2_15_86_1 e_1_2_15_9_1 e_1_2_15_90_1 e_1_2_15_5_1 e_1_2_15_10_1 e_1_2_15_56_1 e_1_2_15_79_1 e_1_2_15_18_1 e_1_2_15_94_1 e_1_2_15_37_1 e_1_2_15_71_1 e_1_2_15_14_1 e_1_2_15_52_1 e_1_2_15_98_1 e_1_2_15_33_1 e_1_2_15_75_1 e_1_2_15_19_1 e_1_2_15_41_1 e_1_2_15_68_1 e_1_2_15_26_1 e_1_2_15_49_1 e_1_2_15_60_1 e_1_2_15_83_1 e_1_2_15_22_1 e_1_2_15_45_1 e_1_2_15_64_1 e_1_2_15_87_1 e_1_2_15_8_1 e_1_2_15_4_1 e_1_2_15_30_1 e_1_2_15_57_1 e_1_2_15_99_1 e_1_2_15_15_1 e_1_2_15_38_1 e_1_2_15_72_1 e_1_2_15_91_1 e_1_2_15_11_1 e_1_2_15_34_1 e_1_2_15_53_1 e_1_2_15_76_1 e_1_2_15_95_1 |
References_xml | – volume: 303 start-page: 1532 issue: 5663 year: 2004 end-page: 1535 article-title: Neutrophil extracellular traps kill bacteria publication-title: Science – volume: 181 start-page: 281 issue: 2 year: 2020 end-page: 292 article-title: Structure, function, and antigenicity of the SARS‐CoV‐2 spike glycoprotein publication-title: Cell – volume: 15 start-page: 547 issue: 6 year: 2018 end-page: 562 article-title: Guillain–Barré syndrome, transverse myelitis and infectious diseases publication-title: Cell Mol Immunol – volume: 205 start-page: 1409 issue: 6 year: 2008 end-page: 1422 article-title: Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection publication-title: J Exp Med – volume: 5 issue: 178 year: 2013 article-title: NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis publication-title: Sci Transl Med – volume: 103 year: 2019 article-title: Bystander activation and autoimmunity publication-title: J Autoimmun – volume: 12 issue: 6 year: 2017 article-title: Prevalence and correlation of cytokine‐specific autoantibodies with epidemiological factors and C‐reactive protein in 8,972 healthy individuals: results from the Danish Blood Donor Study publication-title: PloS one – volume: 98 year: 2021 article-title: Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age‐dependent COVID‐19 morbidity and mortality. A review and hypothesis publication-title: Int Immunopharm – volume: 8 start-page: 487 issue: 5 year: 2007 end-page: 496 article-title: Toll‐like receptor 9‐dependent activation by DNA‐containing immune complexes is mediated by HMGB1 and RAGE publication-title: Nat Immunol – volume: 303 start-page: 1529 issue: 5663 year: 2004 end-page: 1531 article-title: Innate antiviral responses by means of TLR7‐mediated recognition of single‐stranded RNA publication-title: Science – volume: 10 issue: 1 year: 2020 article-title: The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID‐19) publication-title: Sci Rep – volume: 12 issue: 1 year: 2021 article-title: New‐onset IgG autoantibodies in hospitalized patients with COVID‐19 publication-title: Nat Commun – volume: 6 issue: 1 year: 2015 article-title: Neutralization and clearance of GM‐CSF by autoantibodies in pulmonary alveolar proteinosis publication-title: Nat Commun – volume: 95 start-page: 100 year: 2018 end-page: 123 article-title: Molecular mimicry and autoimmunity publication-title: J Autoimmun – volume: 131 issue: 24 year: 2021 article-title: The intersection of COVID‐19 and autoimmunity publication-title: J Clin Invest – volume: 19 start-page: 524 issue: 1 year: 2021 article-title: Paradoxical sex‐specific patterns of autoantibody response to SARS‐CoV‐2 infection publication-title: J Transl Med – volume: 6 issue: 15 year: 2021 article-title: Autoantibodies stabilize neutrophil extracellular traps in COVID‐19 publication-title: JCI insight – volume: 8 year: 2017 article-title: The toll for trafficking: toll‐like receptor 7 delivery to the endosome publication-title: Front Immunol – volume: 8 start-page: 1051 issue: 3 year: 2021 end-page: 1059 article-title: Sjögren’s syndrome and viral infections publication-title: Rheumatology Ther – volume: 17 start-page: 992 issue: 9 year: 2020 end-page: 994 article-title: Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID‐19 patients publication-title: Cell Mol Immunol – volume: 12 year: 2021 article-title: Molecular and biological mechanisms underlying gender differences in COVID‐19 severity and mortality publication-title: Front Immunol – volume: 349 start-page: 643 issue: 6248 year: 2015 end-page: 646 article-title: HUMORAL IMMUNITY. T cell help controls the speed of the cell cycle in germinal center B cells publication-title: Science – volume: 12 issue: 570 year: 2020 article-title: Prothrombotic autoantibodies in serum from patients hospitalized with COVID‐19 publication-title: Sci Transl Med – volume: 49 start-page: 725 issue: 4 year: 2018 end-page: 739 article-title: Distinct effector B cells induced by unregulated toll‐like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus publication-title: Immunity – volume: 370 issue: 6515 year: 2020 article-title: Autoantibodies against type I IFNs in patients with life‐threatening COVID‐19 publication-title: Science – volume: 142 year: 2022 article-title: Mitochondrial DNA and TLR9 activation contribute to SARS‐CoV‐2‐induced endothelial cell damage publication-title: Vasc Pharmacol – volume: 11 issue: 8 year: 2019 article-title: Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms publication-title: Viruses – volume: 35 start-page: 341 issue: 6 year: 2006 end-page: 343 article-title: Reshaping the mosaic of autoimmunity publication-title: Seminars Arthritis Rheumatism – volume: 13 issue: 2 year: 2021 article-title: Human cytomegalovirus and autoimmune diseases: where are we? publication-title: Viruses – volume: 93 start-page: 2735 issue: 5 year: 2021 end-page: 2739 article-title: Role of Toll‐like receptors in the pathogenesis of COVID‐19 publication-title: J Med Virol – volume: 13 start-page: 548 issue: 9 year: 2017 end-page: 560 article-title: Diagnosing antiphospholipid syndrome: ‘extra‐criteria’ manifestations and technical advances publication-title: Nat Rev Rheumatol – volume: 15 issue: 1 year: 2014 article-title: Evidence for non‐neutralizing autoantibodies against IL‐10 signalling components in patients with inflammatory bowel disease publication-title: BMC Immunol – volume: 61 start-page: 160 issue: 1‐2 year: 2015 end-page: 163 article-title: Lupus and leprosy: beyond the coincidence publication-title: Immunol Res – volume: 23 start-page: 194 issue: 2 year: 2022 end-page: 202 article-title: Pathological sequelae of long‐haul COVID publication-title: Nat Immunol – volume: 605 start-page: 349 issue: 7909 year: 2022 end-page: 356 article-title: TLR7 gain‐of‐function genetic variation causes human lupus publication-title: Nature – volume: 13 issue: 2 year: 2021 article-title: Viral infections and systemic lupus erythematosus: new players in an old story publication-title: Viruses – volume: 3 start-page: 371 issue: 6 year: 2022 end-page: 387 article-title: Gastrointestinal symptoms and fecal shedding of SARS‐CoV‐2 RNA suggest prolonged gastrointestinal infection publication-title: Med – volume: 19 issue: 8 year: 2020 article-title: Covid‐19 and autoimmunity publication-title: Autoimmun Rev – volume: 17 start-page: 93 issue: 2 year: 2020 end-page: 110 article-title: Primary biliary cholangitis: pathogenesis and therapeutic opportunities publication-title: Nat Rev Gastroenterol Hepatol – volume: 21 issue: 4 year: 2020 article-title: Autoantibody biomarkers in rheumatic diseases publication-title: Int J Mol Sci – volume: 595 start-page: 283 issue: 7866 year: 2021 end-page: 288 article-title: Diverse functional autoantibodies in patients with COVID‐19 publication-title: Nature – volume: 34 start-page: 85 issue: 1 year: 2008 end-page: 102 article-title: Hepatitis B virus (HBV) and autoimmune disease publication-title: Clin Rev Allergy Immunol – volume: 6 issue: 62 year: 2021 article-title: Autoantibodies neutralizing type I IFNs are present in ∼4% of uninfected individuals over 70 years old and account for ∼20% of COVID‐19 deaths publication-title: Science Immunology – volume: 14 issue: 2 year: 2012 article-title: Anti‐MJ/NXP‐2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis publication-title: Arthritis Res Ther – volume: 27 start-page: 601 issue: 4 year: 2021 end-page: 615 article-title: Post‐acute COVID‐19 syndrome publication-title: Nat Med – volume: 363 start-page: 1544 issue: 9420 year: 2004 end-page: 1546 article-title: Autoantibodies as predictors of disease publication-title: Lancet – volume: 13 start-page: 1077 issue: 6 year: 2020 end-page: 1086 article-title: Clinical and autoimmune characteristics of severe and critical cases of COVID‐19 publication-title: Clinical and translational science – volume: 28 start-page: 879 issue: 5 year: 2022 end-page: 882 article-title: Studying severe long COVID to understand post‐infectious disorders beyond COVID‐19 publication-title: Nat Med – volume: 183 start-page: 143 issue: 1 year: 2020 end-page: 157 article-title: Loss of Bcl‐6‐expressing T follicular helper cells and germinal centers in COVID‐19 publication-title: Cell – volume: 41 start-page: 297 issue: 3 year: 2016 end-page: 301 article-title: A possible link between the Epstein‐Barr virus infection and autoimmune thyroid disorders publication-title: Cent Eur J Immunol – volume: 14 start-page: 373 issue: 3 year: 2019 end-page: 386 article-title: The role of Epstein‐Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging publication-title: Neural Regen Res – volume: 17 start-page: 485 issue: 4 year: 2016 end-page: 498 article-title: Molecular mimicry and autoimmune thyroid disease publication-title: Rev Endocr Metab Disord – volume: 6 issue: 62 year: 2021 article-title: X‐linked recessive TLR7 deficiency in ∼1% of men under 60 years old with life‐threatening COVID‐19 publication-title: Science immunology – volume: 30 start-page: 240 issue: 3 year: 2017 end-page: 249 article-title: Epstein‐barr virus lytic reactivation activates B cells polyclonally and induces activation‐induced cytidine deaminase expression: a mechanism underlying autoimmunity and its contribution to graves' disease publication-title: Viral Immunol – volume: 341 start-page: 2068 issue: 27 year: 1999 end-page: 2074 article-title: Molecular mimicry and autoimmunity publication-title: N. Engl J Med – volume: 12 year: 2021 article-title: NETosis and the immune system in COVID‐19: mechanisms and potential treatments publication-title: Front Pharmacol – volume: 12 start-page: 402 issue: 7 year: 2016 end-page: 413 article-title: The role of neutrophils and NETosis in autoimmune and renal diseases publication-title: Nat Rev Nephrol – volume: 28 start-page: 583 issue: 3 year: 2022 end-page: 590 article-title: Long‐term cardiovascular outcomes of COVID‐19 publication-title: Nat Med – volume: 226 year: 2021 article-title: Coronavirus‐induced autoimmunity publication-title: Clin Immunol – volume: 42 start-page: 39 year: 2013 end-page: 49 article-title: Molecular mimicry rather than identity breaks T‐cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis publication-title: J Autoimmun – volume: 98 start-page: 3988 issue: 7 year: 2001 end-page: 3991 article-title: Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase publication-title: Proc Natl Acad Sci USA – volume: 21 start-page: 1506 issue: 12 year: 2020 end-page: 1516 article-title: Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID‐19 publication-title: Nat Immunol – volume: 383 start-page: 347 issue: 4 year: 2020 end-page: 358 article-title: Multisystem inflammatory syndrome in children in New York state publication-title: N. Engl J Med – volume: 81 start-page: 183 issue: 2 year: 2020 end-page: 189 article-title: Rotavirus and autoimmunity publication-title: J Infect – volume: 10 year: 2019 article-title: B cell dysfunction associated with aging and autoimmune diseases publication-title: Front Immunol – volume: 358 year: 2021 article-title: Herpesviruses and the hidden links to Multiple Sclerosis neuropathology publication-title: J Neuroimmunol – volume: 10 year: 2019 article-title: Functional analysis of anti‐cytokine autoantibodies using flow cytometry publication-title: Front Immunol – volume: 29 start-page: 331 issue: 4 year: 2017 end-page: 342 article-title: Human papilloma virus and lupus: the virus, the vaccine and the disease publication-title: Curr Opin Rheumatol – volume: 16 start-page: 715 issue: 12 year: 2020 end-page: 726 article-title: Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases publication-title: Nat Rev Rheumatol – volume: 79 start-page: 1661 issue: 12 year: 2020 end-page: 1663 article-title: Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID‐19 publication-title: Ann Rheum Dis – volume: 369 start-page: 1210 issue: 6508 year: 2020 end-page: 1220 article-title: Systems biological assessment of immunity to mild versus severe COVID‐19 infection in humans publication-title: Science – volume: 24 start-page: 419 issue: 4‐5 year: 2015 end-page: 432 article-title: Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage publication-title: Lupus – volume: 8 year: 2017 article-title: Thyroid involvement in hepatitis C virus‐infected patients with/without mixed cryoglobulinemia publication-title: Front Endocrinol – volume: 11 year: 2020 article-title: TLR9 and COVID‐19: a multidisciplinary theory of a multifaceted therapeutic target publication-title: Front Pharmacol – volume: 11 start-page: 79 issue: 1 year: 2008 end-page: 89 article-title: Endoglin in angiogenesis and vascular diseases publication-title: Angiogenesis – volume: 185 start-page: 881 issue: 5 year: 2022 end-page: 895 article-title: Multiple early factors anticipate post‐acute COVID‐19 sequelae publication-title: Cell – volume: 45 start-page: 394 issue: 4 year: 2019 end-page: 412 article-title: The role of viral infections in the development of autoimmune diseases publication-title: Crit Rev Microbiol – volume: 183 start-page: 968 issue: 4 year: 2020 end-page: 981 article-title: The immunology of multisystem inflammatory syndrome in children with COVID‐19 publication-title: Cell – volume: 2 issue: 6 year: 2021 article-title: Broad auto‐reactive IgM responses are common in critically ill patients, including those with COVID‐19 publication-title: Cell Rep Med – volume: 6 issue: 1 year: 2016 article-title: Delineation of autoantibody repertoire through differential proteogenomics in hepatitis C virus‐induced cryoglobulinemia publication-title: Sci Rep – volume: 12 year: 2021 article-title: Long COVID or post‐acute sequelae of COVID‐19 (PASC): an overview of biological factors that may contribute to persistent symptoms publication-title: Front Microbiol – volume: 62 start-page: 388 issue: 5 year: 2003 end-page: 393 article-title: Antiphospholipid antibodies and infections publication-title: Ann Rheum Dis – volume: 1 start-page: 136 issue: 2 year: 2012 end-page: 146 article-title: Anti‐cytokine autoantibodies in autoimmune diseases publication-title: Am J Clin Exp Immunol – volume: 40 start-page: 24 issue: 1 year: 2020 end-page: 64 article-title: Human inborn errors of immunity: 2019 update on the classification from the international union of immunological Societies expert committee publication-title: J Clin Immunol – volume: 25 start-page: 417 issue: 3 year: 2006 end-page: 428 article-title: Toll‐like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus publication-title: Immunity – volume: 50 start-page: 1033 issue: 13 year: 2020 end-page: 1042 article-title: Potential functions of atypical memory B cells in Plasmodium‐exposed individuals publication-title: Int J Parasitol – volume: 17 start-page: 98 issue: 2 year: 2021 end-page: 108 article-title: Toll‐like receptor signalling in B cells during systemic lupus erythematosus publication-title: Nat Rev Rheumatol – volume: 131 start-page: 452 issue: 3 year: 2007 end-page: 456 article-title: Anti‐interleukin 8 autoantibody: interleukin 8 immune complexes visualized by laser confocal microscopy in injured lung publication-title: Archives Pathology Laboratory Med – volume: 18 start-page: 716 issue: 7 year: 2017 end-page: 724 article-title: The multiple pathways to autoimmunity publication-title: Nat Immunol – volume: 8 issue: 1 year: 2010 article-title: Rapid induction of autoantibodies during ARDS and septic shock publication-title: J Transl Med – volume: 4 start-page: e329 issue: 5 year: 2022 end-page: e337 article-title: Autoantibodies against interleukin‐1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study publication-title: Lancet Rheumatology – volume: 395 start-page: 497 issue: 10223 year: 2020 end-page: 506 article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China publication-title: Lancet – volume: 17 start-page: 1101 issue: 10 year: 2020 end-page: 1103 article-title: Expansion of atypical memory B cells is a prominent feature of COVID‐19 publication-title: Cell Mol Immunol – volume: 183 start-page: 982 issue: 4 year: 2020 end-page: 995 article-title: Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS‐C) publication-title: Cell – volume: 21 issue: 3 year: 2022 article-title: Autoantibodies and SARS‐CoV2 infection: the spectrum from association to clinical implication: report of the 15th Dresden Symposium on Autoantibodies publication-title: Autoimmun Rev – volume: 13 year: 2022 article-title: SARS‐CoV‐2 infection triggers auto‐immune response in ARDS publication-title: Front Immunol – volume: 15 start-page: 801 issue: 8 year: 2016 end-page: 808 article-title: Zika virus and autoimmunity: from microcephaly to Guillain‐Barré syndrome, and beyond publication-title: Autoimmun Rev – volume: 69 start-page: 279 issue: 4 year: 2016 end-page: 291 article-title: The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease publication-title: J Clin Pathol – ident: e_1_2_15_46_1 doi: 10.1016/s0140‐6736(04)16154‐0 – ident: e_1_2_15_99_1 doi: 10.1016/j.jinf.2020.04.041 – ident: e_1_2_15_5_1 doi: 10.3390/v13020260 – ident: e_1_2_15_23_1 doi: 10.1172/jci154886 – ident: e_1_2_15_38_1 doi: 10.1038/s41598‐020‐76781‐0 – ident: e_1_2_15_69_1 doi: 10.1186/1479‐5876‐8‐97 – ident: e_1_2_15_30_1 doi: 10.1038/s41584‐020‐00544‐4 – ident: e_1_2_15_31_1 doi: 10.1126/sciimmunol.abl4348 – ident: e_1_2_15_51_1 doi: 10.1038/s41584‐020‐00522‐w – ident: e_1_2_15_78_1 doi: 10.1016/j.medj.2022.04.001 – ident: e_1_2_15_57_1 doi: 10.1126/science.abc6261 – ident: e_1_2_15_4_1 doi: 10.3390/v13020277 – ident: e_1_2_15_7_1 doi: 10.1080/1040841x.2019.1614904 – ident: e_1_2_15_90_1 doi: 10.1089/vim.2016.0179 – ident: e_1_2_15_64_1 doi: 10.1038/ncomms8375 – ident: e_1_2_15_42_1 doi: 10.1126/science.abd4585 – ident: e_1_2_15_73_1 doi: 10.1007/s10456‐008‐9101‐9 – ident: e_1_2_15_92_1 doi: 10.1007/s40744‐021‐00334‐8 – ident: e_1_2_15_55_1 doi: 10.3389/fphar.2020.601685 – ident: e_1_2_15_16_1 doi: 10.1038/s41586‐021‐03631‐y – ident: e_1_2_15_45_1 doi: 10.3389/fimmu.2021.659339 – ident: e_1_2_15_10_1 doi: 10.1016/j.jaut.2018.10.012 – ident: e_1_2_15_27_1 doi: 10.1126/science.1093616 – ident: e_1_2_15_75_1 doi: 10.1038/s41590‐021‐01104‐y – ident: e_1_2_15_96_1 doi: 10.1097/bor.0000000000000398 – ident: e_1_2_15_39_1 doi: 10.1172/jci.insight.150111 – ident: e_1_2_15_2_1 doi: 10.1016/j.clim.2021.108694 – ident: e_1_2_15_59_1 doi: 10.1038/nrrheum.2017.124 – ident: e_1_2_15_67_1 doi: 10.1371/journal.pone.0179981 – ident: e_1_2_15_77_1 doi: 10.1038/s41591‐022‐01766‐7 – ident: e_1_2_15_48_1 doi: 10.3390/ijms21041382 – ident: e_1_2_15_71_1 doi: 10.1016/j.cell.2020.09.016 – ident: e_1_2_15_41_1 doi: 10.1038/s41591‐021‐01283‐z – ident: e_1_2_15_11_1 doi: 10.3390/v11080762 – ident: e_1_2_15_18_1 doi: 10.1016/j.xcrm.2021.100321 – ident: e_1_2_15_17_1 doi: 10.1038/s41467‐021‐25509‐3 – ident: e_1_2_15_14_1 doi: 10.1016/j.autrev.2021.103012 – ident: e_1_2_15_95_1 doi: 10.1038/srep29532 – ident: e_1_2_15_88_1 doi: 10.1073/pnas.071050898 – ident: e_1_2_15_22_1 doi: 10.1016/j.cell.2022.01.014 – ident: e_1_2_15_87_1 doi: 10.3390/v13020277 – ident: e_1_2_15_43_1 doi: 10.1016/j.cell.2020.09.034 – ident: e_1_2_15_62_1 doi: 10.3389/fimmu.2019.01517 – ident: e_1_2_15_94_1 doi: 10.3389/fendo.2017.00159 – ident: e_1_2_15_70_1 doi: 10.3389/fimmu.2022.732197 – ident: e_1_2_15_54_1 doi: 10.1016/j.vph.2021.106946 – ident: e_1_2_15_76_1 doi: 10.1038/s41591‐022‐01689‐3 – ident: e_1_2_15_63_1 doi: 10.1186/1471‐2172‐15‐10 – ident: e_1_2_15_13_1 doi: 10.1016/s0140‐6736(20)30183‐5 – ident: e_1_2_15_61_1 doi: 10.1007/s10875‐019‐00737‐x – ident: e_1_2_15_79_1 doi: 10.1016/j.ijpara.2020.08.003 – ident: e_1_2_15_44_1 doi: 10.1186/s12967‐021‐03184‐8 – volume: 1 start-page: 136 issue: 2 year: 2012 ident: e_1_2_15_66_1 article-title: Anti‐cytokine autoantibodies in autoimmune diseases publication-title: Am J Clin Exp Immunol contributor: fullname: Cappellano G – ident: e_1_2_15_20_1 doi: 10.1038/s41590‐020‐00814‐z – ident: e_1_2_15_86_1 doi: 10.1038/s41575‐019‐0226‐7 – ident: e_1_2_15_68_1 doi: 10.1126/sciimmunol.abl4340 – ident: e_1_2_15_97_1 doi: 10.1136/jclinpath‐2015‐203455 – ident: e_1_2_15_21_1 doi: 10.1016/j.cell.2020.11.032 – ident: e_1_2_15_3_1 doi: 10.1016/j.semarthrit.2005.09.002 – ident: e_1_2_15_12_1 doi: 10.1016/j.jaut.2019.06.012 – ident: e_1_2_15_15_1 doi: 10.3389/fmicb.2021.698169 – ident: e_1_2_15_32_1 doi: 10.3389/fimmu.2019.00318 – ident: e_1_2_15_25_1 doi: 10.1016/j.cell.2020.08.025 – ident: e_1_2_15_26_1 doi: 10.1016/j.immuni.2018.08.015 – ident: e_1_2_15_9_1 doi: 10.1056/nejm199912303412707 – ident: e_1_2_15_33_1 doi: 10.1016/j.intimp.2021.107806 – ident: e_1_2_15_36_1 doi: 10.1126/scitranslmed.3005580 – ident: e_1_2_15_89_1 doi: 10.5114/ceji.2016.63130 – ident: e_1_2_15_40_1 doi: 10.1126/scitranslmed.abd3876 – ident: e_1_2_15_19_1 doi: 10.1016/j.autrev.2020.102597 – ident: e_1_2_15_83_1 doi: 10.1007/s11154‐016‐9363‐2 – ident: e_1_2_15_93_1 doi: 10.1007/s12016‐007‐8013‐6 – ident: e_1_2_15_84_1 doi: 10.1177/0961203314558677 – ident: e_1_2_15_8_1 doi: 10.1038/ni.3731 – ident: e_1_2_15_65_1 doi: 10.5858/2007‐131‐452‐aaicvb – ident: e_1_2_15_81_1 doi: 10.1016/j.jaut.2012.11.001 – ident: e_1_2_15_60_1 doi: 10.1136/ard.62.5.388 – ident: e_1_2_15_58_1 doi: 10.1038/s41423‐020‐0492‐x – ident: e_1_2_15_74_1 doi: 10.1016/s2665‐9913(22)00064‐9 – ident: e_1_2_15_53_1 doi: 10.1002/jmv.26826 – ident: e_1_2_15_6_1 doi: 10.1016/j.jneuroim.2021.577636 – ident: e_1_2_15_82_1 doi: 10.1084/jem.20071859 – ident: e_1_2_15_100_1 doi: 10.1016/j.autrev.2016.03.020 – ident: e_1_2_15_49_1 doi: 10.1136/annrheumdis‐2020‐218009 – ident: e_1_2_15_34_1 doi: 10.1126/science.1092385 – ident: e_1_2_15_56_1 doi: 10.1038/ni1457 – ident: e_1_2_15_47_1 doi: 10.1186/ar3822 – ident: e_1_2_15_29_1 doi: 10.3389/fimmu.2017.01075 – ident: e_1_2_15_37_1 doi: 10.3389/fphar.2021.708302 – ident: e_1_2_15_80_1 doi: 10.1038/s41423‐020‐00542‐2 – ident: e_1_2_15_28_1 doi: 10.1038/s41586‐022‐04642‐z – ident: e_1_2_15_35_1 doi: 10.1038/nrneph.2016.71 – ident: e_1_2_15_98_1 doi: 10.1007/s12026‐014‐8596‐y – ident: e_1_2_15_24_1 doi: 10.1126/science.aac4919 – ident: e_1_2_15_85_1 doi: 10.1038/cmi.2017.142 – ident: e_1_2_15_91_1 doi: 10.4103/1673‐5374.245462 – ident: e_1_2_15_52_1 doi: 10.1016/j.immuni.2006.07.013 – ident: e_1_2_15_72_1 doi: 10.1056/nejmoa2021756 – ident: e_1_2_15_50_1 doi: 10.1111/cts.12805 |
SSID | ssj0010104 |
Score | 2.4450874 |
SecondaryResourceType | review_article |
Snippet | Autoantibodies (AABs) play a critical role in the pathogenesis of autoimmune diseases (AIDs) and serve as a diagnostic and prognostic tool in assessing these... Abstract Autoantibodies (AABs) play a critical role in the pathogenesis of autoimmune diseases (AIDs) and serve as a diagnostic and prognostic tool in... |
SourceID | pubmedcentral proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e2412 |
SubjectTerms | Autoantibodies autoantibody (AAB) Autoimmune diseases Autoimmunity Cell activation Child Complications COVID-19 Crime Cytokine storm Cytokines Environmental factors Humans Inflammation Leukocytes (neutrophilic) Multisystem inflammatory syndrome in children Neutrophils Pathogenesis Post-Acute COVID-19 Syndrome Respiratory distress syndrome Review SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Thrombosis |
Title | Partners in crime: Autoantibodies complicit in COVID‐19 pathogenesis |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Frmv.2412 https://www.ncbi.nlm.nih.gov/pubmed/36471421 https://www.proquest.com/docview/2785187103 https://pubmed.ncbi.nlm.nih.gov/PMC9877745 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dS-QwFL2IoPiy6-fa9YMuiG8dkzSdTHwTdVDBD0RF8KGkaapFtrM4HUGf_An-Rn-JuWk7Ooog-9SHpiXNSXJPmptzANaijsiMFCrQkeZoYaYDpaQItM6YjUA86WQu2-KovXfODy6jyzqrEs_CVPoQwx9uODLcfI0DXCX9jTfR0Lu_9y0bfnD6RR095EOnQ-UoissMt9EZsUAy0W50ZwnbaB4cjUSf6OXnLMn37NWFn-5PuGoqXmWd3LYGZdLSjx80Hf_vy6bhR81K_a2qG83AmClmYaLyqXyYhcnDegd-Drontq8VljP6eeFr9AbY9LcGZc8ClCc9TEn06yz1vMQi28cX-zsvT89U-mh-3LvGuTXvz8N5d_dsey-ovRgCjVuFgWKZVFy0lcraqRRRhMp7JCMkDaVRlBvCU2IMoSkXhkpNtKV2qUosEFJLk4ULMF70CrMIvnP7iHjoDkAInSpmZEippjrsmCTJPPjT4BL_qyQ34kpcmcW2aWJsGg-WG8DietD1YyYsfbQLQBJ68KvCbvgClMmnnFEPxAiqwwIosz16p8hvnNy2RMlEHnmw7kD7sk7x6eEFXn9_t-ASTKF5fZXRtgzj5d3ArFiKUyarrjO_AukY-Ns |
link.rule.ids | 230,315,786,790,891,1382,27955,27956,46327,46751 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0hUD8utIV-hFIapIpbFtux1-tyQtDVUlhaIUAcKkWO40BUkUWQRWpP_Qn9jf0leJxkYUGVqp5yiB05fh7Psz1-A_BB9GRuldSREYZjCjMTaa1kZEzOnAfiaS_30Rb73cER_3wiTmZgo70LU-tDTDbc0DL8fI0GjhvS67eqoZfn1x3nf9z8O-esXaBVbh9MtKMoLjT8UadgkWKy2yrPErbe1pz2RQ8I5sM4ybv81Tug_jP41ja9jjv53hlXacf8vKfq-J__9hzmG2IabtYj6QXM2HIBHtWpKn8swONhcwi_CP2vbriVjjaGRRkaTA_wMdwcVyOHUZGOMCoxbALViwqLbH053tn-8-s3VSHmPx6d4vRaXL2Eo_6nw61B1KRjiAyeFkaa5Upz2dU672ZKCoHieyQnJIuV1ZRbwjNiLaEZl5YqQ4xjd5lOHRLKKJvHr2C2HJX2DYQ-4Yfgsb8DIU2mmVUxpYaauGfTNA9gtQUmuahVN5JaX5klrmsS7JoAllvEksburhImHYN0a0ASB_C6Bm_yAVTKp5zRAOQUrJMCqLQ9_aYszrzitkLVRC4CWPOo_bVNycHwGJ9L_1rwPTwZHA73kr2d_d238BRz2dcBbsswW12O7TvHeKp0xY_sG3bQ_Ps |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL1CRVRsCrSlBAoNEuouU9tx4jG70QyjPmipKlpV6iJyHLtEFZmqzSDBik_gG_kSfJ1kYFohVV1lESdyfGzf4_j6HIB3SV9YI4WKdKI5WpjpSCkpIq0tcxGI533rsy0O0u1jvnuanLZZlXgWptGHmP1ww5Hh52sc4JeF3forGnr19VvPhR83_T7kacxw4TU6mklHUVxn-J3OhEWSibQTniVsq3tyPhTd4pe30yT_pa8-_oyfwFlX8ybt5KI3rfOe_nFD1PF-n_YUllpaGg6afvQMHphqGR41RpXfl2Fxv92CX4HxoetslSONYVmFGs0B3oeDaT1xCJX5BHMSwzZNvayxyPDTyc7o989fVIbofjw5x8m1vF6F4_GHz8PtqDVjiDTuFUaKWam4SJWyaSFFkqD0HrGEFLE0inJDeEGMIbTgwlCpiXbcrlC5A0JqaWz8HBaqSWVeQOjtPhIe-xMQQheKGRlTqqmO-ybPbQBvO1yyy0ZzI2vUlVnmmibDpglgvQMsa0fddcaE449uBUjiANYa7GYvQJ18yhkNQMyhOiuAOtvzd6ryi9fblqiZyJMANj1o_61TdrR_gteXdy24AYuHo3H2cedg7xU8RiP7JrttHRbqq6l57ehOnb_x_foPjh37qg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Partners+in+crime%3A+Autoantibodies+complicit+in+COVID-19+pathogenesis&rft.jtitle=Reviews+in+medical+virology&rft.au=Taghadosi%2C+Mahdi&rft.au=Safarzadeh%2C+Elham&rft.au=Asgarzadeh%2C+Ali&rft.au=Roghani%2C+Seyed+Askar&rft.date=2023-03-01&rft.eissn=1099-1654&rft.volume=33&rft.issue=2&rft.spage=e2412&rft_id=info:doi/10.1002%2Frmv.2412&rft_id=info%3Apmid%2F36471421&rft.externalDocID=36471421 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1052-9276&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1052-9276&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1052-9276&client=summon |